Cargando…
M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma
LncRNA N6-methylandenosine (m6A) modification has been shown to be associated with the constitution of the tumor microenvironment (TME) and tumorigenesis. It’s essential to understand the mechanisms of lncRNA m6A modification in hepatocellular carcinoma (HCC) and identify relative prognostic predict...
Autores principales: | Chen, Bo, Yang, Zhan, Lang, Zhichao, Tao, Qiqi, Zhang, Rongrong, Zhan, Yating, Xu, Xuantong, Zhu, Kai, Zheng, Jianjian, Yu, Zhengping, Yu, Suhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361634/ https://www.ncbi.nlm.nih.gov/pubmed/35941582 http://dx.doi.org/10.1186/s12885-022-09925-2 |
Ejemplares similares
-
Construction of a novel exosomes-related gene signature in hepatocellular carcinoma
por: Tao, Qiqi, et al.
Publicado: (2022) -
Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma
por: Tao, Qiqi, et al.
Publicado: (2023) -
Tumor immune microenvironment lncRNAs
por: Park, Eun-Gyeong, et al.
Publicado: (2021) -
20(S)- Protopanaxadiol suppresses hepatic stellate cell activation via WIF1 demethylation-mediated inactivation of the Wnt/β-catenin pathway
por: Li, Chunxue, et al.
Publicado: (2023) -
Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2023)